| P50 | author | Jeffrey Bajramovic | Q56794153 |
| P2093 | author name string | Sylvie Syan | |
| | Michel Brahic | |
| | Juan Carlos de la Torre | |
| | Daniel Gonzalez-Dunia | |
| P2860 | cites work | Nuclear Retention of IκBα Protects It from Signal-induced Degradation and Inhibits Nuclear Factor κB Transcriptional Activation | Q60304974 |
| | Inhibition of mammalian DNA polymerase by the 5'-triphosphate of 1-beta-d-arabinofuranosylcytosine and the 5'-triphosphate of 9-beta-d-arabinofuranoxyladenine | Q72310743 |
| | Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme | Q77333600 |
| | Borna disease virus persistent infection activates mitogen-activated protein kinase and blocks neuronal differentiation of PC12 cells. | Q31552307 |
| | Isolation of Borna disease virus from human brain tissue | Q33804447 |
| | Pathogenesis of borna disease virus: granulocyte fractions of psychiatric patients harbor infectious virus in the absence of antiviral antibodies. | Q33816410 |
| | Borna disease virus and human disease | Q34296879 |
| | Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1 | Q34685189 |
| | The Mechanism of Action of Inhibitors of DNA Synthesis | Q35521784 |
| | Sequence and genome organization of Borna disease virus | Q36628426 |
| | Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells | Q37121596 |
| | Characterization of Borna disease virus p56 protein, a surface glycoprotein involved in virus entry | Q38559106 |
| | Borna disease virus: implications for human neuropsychiatric illness | Q38573259 |
| | Borna disease: a persistent virus infection of the central nervous system | Q39529919 |
| | Inhibition of Borna disease virus replication by ribavirin | Q39551221 |
| | The mechanisms of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA) | Q39635068 |
| | Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present. | Q40039339 |
| | Molecular biology of borna disease virus: prototype of a new group of animal viruses | Q40042752 |
| | Borna disease: association with a maturation defect in the cellular immune response | Q40113418 |
| | Borna disease--neuropathology and pathogenesis. | Q40549665 |
| | The remarkable coding strategy of borna disease virus: a new member of the nonsegmented negative strand RNA viruses | Q40551514 |
| | Inhibition of DNA polymerase-α and -β of calf thymus by 1-β-d-arabinofuranosylcytosine-5′-triphosphate | Q40787067 |
| | Borna disease virus (BDV), a (zoonotic?) worldwide pathogen. A review of the history of the disease and the virus infection with comprehensive bibliography. | Q40895251 |
| | Borna disease virus nucleoprotein requires both nuclear localization and export activities for viral nucleocytoplasmic shuttling | Q40906652 |
| | Enhancement of Borna disease virus transcription in persistently infected cells by serum starvation | Q40933936 |
| | Inhibition of Borna disease virus replication by ribavirin in persistently infected cells | Q40987799 |
| | Lack of antiviral effect of amantadine in Borna disease virus infection | Q41045354 |
| | Amantadine does not have antiviral activity against Borna disease virus | Q41136868 |
| | Borna disease virus replicates in astrocytes, Schwann cells and ependymal cells in persistently infected rats: location of viral genomic and messenger RNAs by in situ hybridization | Q41790548 |
| | Rabies and borna disease. A comparative pathogenetic study of two neurovirulent agents | Q42620361 |
| | The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen | Q43545743 |
| | Antigenic relationship and further characterization of two major Borna disease virus-specific proteins | Q44286393 |
| | Borna disease virus-specific circulating immune complexes, antigenemia, and free antibodies--the key marker triplet determining infection and prevailing in severe mood disorders | Q45736577 |
| | Borna disease virus and neuropsychiatric disease--a reappraisal | Q45736661 |
| | Borna disease virus is not sensitive to amantadine | Q45758853 |
| | Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression | Q45763733 |
| | Detection of borna disease virus antigen and RNA in human autopsy brain samples from neuropsychiatric patients | Q45768244 |
| | Early and persistent abnormalities in rats with neonatally acquired Borna disease virus infection | Q45778338 |
| | Borna disease virus genome transcribed and expressed in psychiatric patients | Q45788458 |
| | Demonstration of human Borna disease virus RNA in human peripheral blood mononuclear cells | Q45789227 |
| | Replication of Borna disease virus in cell cultures | Q45794390 |
| | Behavioral disease in rats caused by immunopathological responses to persistent borna virus in the brain | Q45795230 |
| | Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders | Q45828546 |
| | Learning deficiencies in Borna disease virus-infected but clinically healthy rats | Q45846684 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytarabine | Q180983 |
| | Borna disease | Q9430213 |
| | pathogen spread | Q50156634 |
| P304 | page(s) | 6268-6276 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | 1-beta-D-arabinofuranosylcytosine inhibits borna disease virus replication and spread | |
| P478 | volume | 76 | |